01 1Dasami Lab
01 1GABAPENTIN ENACARBIL
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-10
Pay. Date : 2019-02-21
DMF Number : 33386
Submission : 2019-03-29
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GABAPENTIN ENACARBIL, with a corresponding US DMF Number 33386.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 10, 2019, and payment made on February 21, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
